Survodutide has a novel mechanism of action (agonism of the dual GCG/GLP-1 receptors) that may have direct effects on energy expenditure in the liver in addition to decreasing appetite
GenWorks has scaled up its e-commerce platform in terms of building traffic
The booster vaccine can be administered safely to individuals who have received two doses of either Covaxin or Covishield
The partnership aims to prioritize the diagnosis and treatment of these diseases while working to reducing their long-term prevalence
Acquisition delivers industry-leading research capability, and strengthens pipeline with a novel candidate for ulcerative colitis, Crohn’s disease and other autoimmune conditions
Based on a subgroup analysis by PD-L1 expression from KEYNOTE-811, Merck is working with the US FDA to update the current indication for KEYTRUDA in HER2-positive gastric or GEJ adenocarcinoma
Authorisation will help protect adults 60 years of age and older in 30 European countries* from RSV disease for the first time
Data support that antibiotic aztreonam-avibactam (ATM-AVI) is effective and well-tolerated in treating infections caused by Gram-negative bacteria, with a similar safety profile to aztreonam alone
The Global Medical Countermeasures Platform will provide equal access safe, high-quality, cost-effective medical countermeasures to the world
Subscribe To Our Newsletter & Stay Updated
